Relation between 1H MR spectroscopic imaging and regional cerebral glucose metabolism in Alzheimer's disease

International Journal of Neuroscience

Volumn 107, Issue 3-4, 2001, Pages 233-245

  Mielke, Ruediger ^a   Schopphoff, Hans Helge ^a   Kugel, Harald ^b   Pietrzyk, Uwe ^a   Heindel, Walter ^c   Kessler, Joseph ^a   Heiss, Wolf Dieter ^a  

^a MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Alzheimer's disease; Cerebral glucose metabolism; Choline; Emission computed tomography; Magnetic resonance spectroscopic imaging; N acetyl aspartate

Indexed keywords

ASPARTIC ACID; CHOLINE; DRUG DERIVATIVE; GLUCOSE; N ACETYLASPARTIC ACID; N-ACETYLASPARTATE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SCINTISCANNING;

ADULT; AGED; ALZHEIMER DISEASE; ASPARTIC ACID; BRAIN; CHOLINE; FEMALE; GLUCOSE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034744333     PISSN: 00207454     EISSN: None     Source Type: Journal    
DOI: 10.3109/00207450109150687     Document Type: Article

References (22)

1. Anderson, J. H., Strandberg, J. D., Wong, D. F., Conti, P. S., Barker, P. B., Blackband, S. J., Hilton, J., Natarajan, T. K., Dannals, R. F. & Samphilipo, M. A. (1994) Multimodality correlative study of canine brain tumors. Proton magnetic resonance spectroscopy, positron emission tomography, and histology. Investigational Radiology, 29, 597-605.
2. Barany, M., Chang, Y. C., Arus, C., Rustan, T. & Frey, W. H. (1985) Increased glycerol-3-phosphorylcholine in post-mortem Alzheimer's brain. Lancet, 1(8427), 517.
3. Bates, T. E., Strangward, M., Keelan, J., Davey, G. P., Munro, P. M. & Clark, J. B. (1996) Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo. Neuroreport, 7, 1397-400.
4. Bhakoo, K. K. & Pearce, D. (2000) In vitro expression of N-acetyl aspartate by oligodendrocytes: implications for proton magnetic resonance spectroscopy signal in vivo. Journal of Neurochemislry, 74, 254-262.
5. Blusztajn, J. K., Holbrook, P. G., Lakher, M., Liscovitch, M., Maire, J. C., Mauron, C., Richardson, U. I., Tacconi, M. & Wurtman, R. J. (1986) "Autocannibalism" of membrane choline-phospholipids: physiology and pathology. Psychopharmacological Bulletin, 22, 781-786.
6. Bottomley, P. A. (1987) Spatial localization in NMR spectroscopy in vivo. Annals of the New York Academy of Sciences, 508, 333-48.
7. Bottomley, P. A. (1989) Human in vivo NMR spectroscopy in diagnostic medicine: clinical tool or research probe? Radiology, 170, 1-15.
8. Christiansen, P., Schlosser, A. & Henriksen, O. (1995) Reduced N-acetylaspartate content in the frontal part of the brain in patients with probable Alzheimer's disease. Magnetic Resonance Imaging, 13, 457-62.
9. 1H NMR Spectroscopy and spectroscopic imaging of the human brain. In: Diehl, P., Fluch, E., Günther, H., Kosfeld, R. and Seelig, J. (Eds.), NMR basic principles and progress. Invivo magnetic resonance spectroscopy II: localization and spectral editing (pp. 151-175). Berlin Heidelberg New York: Springer-Verlag.
10. Ernst, T. & Chang, L. (1996) Elimination of artifacts in short echo time H MR spectroscopy of the frontal lobe. Magnetic Resonance Medicine, 36, 462-8.
11. Folstein, M. F., Folstein, S. E. & McHugh, P. R. (1975) Mini-mental state. Journal of Psychiatry Reserach, 12, 189-198.
12. Frederick, B. B., Satlin, A., Yurgelun-Todd, D. A. & Renshaw, P. F. (1997) In vivo proton magnetic resonance spectroscopy of Alzheimer's disease in the parietal and temporal lobes. Biological Psychiatry, 42, 147-150.
13. Herholz, K., Adams, R., Kessler, J., Szelies, B., Grond, M. & Heiss, W. D. (1990) Criteria for the diagnosis of Alzheimer's disease with positron emission tomography. Dementia, 1, 156-164.
14. Ibanez, V., Pietrini, P., Alexander, G. E., Furey, M. L., Teichberg, D., Rajapakse, J. C., Rapoport, S. I., Schapiro, M. B. & Horwitz, B. (1998) Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology, 50, 1585-1593.
15. Ide, M., Naruse, S. & Furuya, S. (1997) IH-MRSI of Alzheimer's disease. Nippon Rinsho - Japanese Journal of Clinical Medicine, 55, 1768-73.
16. Jope, R. S. & Jenden, D. J. (1979) Choline and phospholipid metabolism and the synthesis of acetylcholine in rat brain. Journal of Neuroscience Research, 4, 69-82.
17. Klunk, W. E., Panchalingham, K., Mossy, J., McClure, R. J. & Pettegrew, J. W. (1992) NAA and other amino acid metabolites in Alzheimer's disease brain. Neurology, 42, 1578-1585.
18. Kwo-On-Yuen, P. F., Newmark, R. D., Budinger, T. F., Kaye, J. A., Ball, M. J. & Jagust, W. J. (1994) Brain N-acetyl-L-aspartic acid in Alzheimer's disease: a proton magnetic resonance spectroscopy study. Brain Research, 667, 167-174.
19. Lazeyras, F., Charles, H. C., Tupler, L. A., Erickson, R., Boyko, O. B. & Krishnan, K. R. (1998) Metabolic brain mapping in Alzheimer's disease using proton magnetic resonance spectroscopy. Psychiatry Research, 82, 95-106.
20. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. & Stadlan, E. M. (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology, 19, 939-944.
21. Meyerhoff, D. J., MacKay, S., Constans, J. M., Norman, D., Van Dyke, C., Fein, G. & Weiner, M. W. (1994) Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging. Annals of Neurology, 36, 40-47.
22. Mielke, R., Herholz, K., Grond, M., Kessler, J. & Heiss, W. D. (1992) Severity of vascular dementia is related to volume of metabolically impaired tissue. Archives of Neurology, 49, 909-913.